Synthetic Biology: New Tools, New Approaches, New Thinking- Interview with Professor Paul Freemont
As part of our Future Pharma series, Pharma IQ is examining the promise held by synthetic biology. Our editor spoke to Professor Paul Freemont Chair in Protein Crystallography and Co-Founder and Co-Director of the EPSRC Centre for Synthetic Biology and Innovation at Imperial College London. Professor Freemont Describes the current technical challenges which this exciting field is seeking to overcome, some of the most exciting projects and how synthetic biology will change the pharma industry....
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.